Stephen A Firkins
Overview
Explore the profile of Stephen A Firkins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sierra L, Chatterjee A, Khurana A, Prado R, Patel R, Firkins S, et al.
ACG Case Rep J
. 2025 Mar;
12(3):e01631.
PMID: 40051904
The study is the first to assess the argon-plasma coagulation ArC Smart linear beam for mucosal ablation in transoral outlet reduction for weight regain after Roux-en-Y gastric bypass. The noncontact...
2.
Wehbe S, Firkins S, Sweeney J, Moore H, Rouphael C
ACG Case Rep J
. 2025 Jan;
12(1):e01582.
PMID: 39829946
Breast cancer (BC) is a common cancer in females. Spread to the gastrointestinal tract is rare. This is a 61-year-old woman with history of T2N0M0 lobular BC treated 5 years...
3.
Firkins S, Yoo H, Simons-Linares R
VideoGIE
. 2024 Oct;
9(10):433-435.
PMID: 39473553
No abstract available.
4.
Iyer M, Firkins S, Patel R, Flora B, Staneff E, Simons-Linares R
ACG Case Rep J
. 2024 Sep;
11(9):e01514.
PMID: 39267621
Patients with hereditary polyposis syndromes (HPS) are among the highest risk of multiple types of cancer. This risk is further magnified by comorbid obesity; however, HPS present unique risks for...
5.
Firkins S, Simons-Linares R
Best Pract Res Clin Gastroenterol
. 2024 Jul;
70:101926.
PMID: 39053976
No abstract available.
6.
Firkins S, Yates J, Shukla N, Garg R, Vargo J, Lembo A
Clin Gastroenterol Hepatol
. 2024 Apr;
PMID: 38574832
Glucose-like peptide-1-receptor agonists (GLP-1RAs) have become integral to the management of type 2 diabetes and obesity. GLP-1RAs work in part through delaying gastric emptying, raising concerns about retained gastric contents...
7.
Elsaid M, Li N, Firkins S, Rustgi V, Paskett E, Acharya C, et al.
Aliment Pharmacol Ther
. 2024 Mar;
59(9):1096-1110.
PMID: 38538967
Background/aims: We examined the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) initiation on long-term Adverse Liver Outcomes (ALO) in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) cirrhosis and type...
8.
Firkins S, Chittajallu V, Flora B, Yoo H, Simons-Linares R
Obes Surg
. 2024 Mar;
34(5):1415-1424.
PMID: 38512645
Purpose: A significant proportion of patients experience insufficient weight loss or weight regain after bariatric surgery. There is a paucity of literature describing anti-obesity medication (AOM) use following bariatric surgery....
9.
Twohey E, Hasley I, Shaeffer P, Ceremuga G, Firkins S, Stringer G, et al.
Arch Rehabil Res Clin Transl
. 2024 Jan;
5(4):100301.
PMID: 38163040
Objective: To compare validity indices of the King-Devick (KD) test and Sport Concussion Assessment Tool 5 (SCAT5) for traumatic events in MMA, and to determine if perfusion events (alterations in...
10.
Yoo H, Firkins S, Kwon A, Imperio-Lagabon K, Bajwa R, Flora B, et al.
Surg Obes Relat Dis
. 2023 Nov;
20(3):254-260.
PMID: 37996260
Background: Marginal ulceration (MU) is a significant cause of morbidity after Roux-en-Y gastric bypass (RYGB). Proton pump inhibitors (PPIs) are the primary treatment. Prior limited data suggest that open-capsule PPIs...